Roivant Sciences Ltd.(NasdaqGS:ROIV) added to S&P 400 Health Care (Sector)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.13 USD | -1.07% | -2.28% | -0.89% |
04-05 | Arbutus Biopharma Obtains Favorable Court Order in Moderna Patent Lawsuit | MT |
04-04 | Moderna Suffers Setback in Lawsuit by Arbutus | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.89% | 8.97B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- ROIV Stock
- News Roivant Sciences Ltd.
- Roivant Sciences Ltd.(NasdaqGS: ROIV) added to S&P 400 Health Care